Latest

Hepatic Cirrhosis: Comprehensive Market Intelligence, Epidemiology, and Forecast Analysis Through 2032

7 April 2026
DelveInsight’s “Hepatic Cirrhosis Market Insights, Epidemiology, and Market Forecast-2032” analysis provides comprehensive understanding of Hepatic Cirrhosis, encompassing historical and projected epidemiology alongside market trajectories across the United States, EU5 nations (Germany, Spain, Italy, France, and United Kingdom), and Japan. Download analysis @https://www.delveinsight.com/report-store/hepatic-cirrhosis-market?utm_source=pngw&utm_medium=pr&utm_campaign=kkpr

Spondylolisthesis Market Poised for Significant Growth Driven by Advanced Spinal Therapies, Rising Disease Burden, and Expanding Surgical Innovation Across Seven Major Countries

6 April 2026
Spondylolisthesis Market Summary The Spondylolisthesis market is undergoing a significant transformation as heightened awareness, evolving clinical protocols, and next-generation spinal technologies converge to address a condition that affects millions worldwide. DelveInsight’s latest market analysis reveals that the spondylolisthesis treatment landscape is expanding

Spinocerebellar Ataxias Market: Emerging Therapies, Epidemiological Trends, and Pipeline Innovations Reshaping Neurological Care

1 April 2026
Spinocerebellar Ataxia (SCA) is among the most complex and debilitating inherited neurological disorders, characterized by progressive cerebellar degeneration and a wide spectrum of neurological manifestations. As the scientific community deepens its understanding of this heterogeneous disease, the Spinocerebellar Ataxias market continues to

Smoking Cessation and Nicotine Addiction Market: Comprehensive Analysis of Epidemiology, Emerging Therapies, and Growth Opportunities Across Seven Major Markets Through 2034

1 April 2026
Smoking Cessation and Nicotine Addiction Market Summary The Smoking Cessation and Nicotine Addiction market continues to evolve rapidly, driven by increasing awareness of tobacco-related health consequences, expanding pipeline therapies, and growing governmental and institutional support for cessation programs. According to the latest
1 12 13 14 15 16 31